title: More on periorbital infections following therapy with biological agents.
authors.forename: Davide
authors.initials: D
authors.lastname: Lazzeri
authors.forename: Tommaso
authors.initials: T
authors.lastname: Agostini
authors.forename: Michele
authors.initials: M
authors.lastname: Figus
authors.forename: Marco
authors.initials: M
authors.lastname: Nardi
authors.forename: Marcello
authors.initials: M
authors.lastname: Pantaloni
authors.forename: Stefano
authors.initials: S
authors.lastname: Lazzeri
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D054517:Orbital Cellulitis / Q000382:microbiology*; D013290:Streptococcal Infections / Q000382:microbiology*; D013297:Streptococcus pyogenes
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents